retatrutide mechanism triple agonist glp-1 gip glucagon ly3437943 A review of an investigational drug retatrutide, a novel agent for the treatment of obesity | European Journal of Clinical Pharmacology Retatrutide—A Game Changer in Obesity
Pay in 4 interest-free payments of $7.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21






















